FDA Grants Orphan Drug Designation to Soquelitinib in T-Cell Lymphoma

Soquelitinib has been granted an orphan drug designation by the FDA for potential use in T-cell lymphoma.

Related Keywords

,Richarda Miller ,Xie Yan ,Corvus Pharmaceuticals Inc ,Corvus Pharmaceuticals ,Cart Cell Therapy ,News ,Soquelitinib ,T Cell Lymphoma ,